Abstract:Objective: This study aimed to screen lead compounds and medication candidates from drug library (ZINC database) which has potential agonist effect targeting STING protein. Methods and materials: A series of computer-aided virtual screening techniques were utilized to identify potential agonists of STING. Structure-based screening using Libdock was carried out followed by ADME (absorption, distribution, metabolism, excretion) and toxicity prediction. Molecular docking was performed to demonstrate the binding affinity and mechanism between ligands and STING dimers. Molecular dynamic simulation was utilized to evaluate the stability of ligand-receptor complex. Finally, animal experiment was conducted to validate the effectiveness of selected compounds. Results: Three novel natural compounds 1,2,3 (ZINC000015149223, ZINC000011616633 and ZINC000001577210, respectively) from the ZINC15 database were found binding to STING with more favorable interaction energy. Also, they were predicted with less ames mutagenicity, rodent carcinogenicity, non-developmental toxic potential and tolerant with cytochrome P450 2D6 (CYP2D6). The ligand chemical structure analysis showed the three compounds were inborn axisymmetric, such chemical structures account for combining and activating process of STING protein dimers. The dynamic simulation analysis demonstrated that ZINC000015149223-, ZINC000011616633- and ZINC000001577210-STING dimer complex had more favorable potential energy compared with amidobenzimidazole (ABZI) and they can exist in natural environments stably. Animal experiments also demonstrated that these three compounds could suppress tumor growth. Conclusion: This study demonstrates that ZINC000015149223, ZINC000011616633 and ZINC000001577210 are potential agonists targeting STING protein. These compounds are safe drug candidates and have a great significance in STING agonists development.

Bioorthogonal imaging probe for STING protein in live cell and fixed tissue

Development of STING probes and visualization of STING in multiple tumor types

Optogenetic Engineering to Probe the Molecular Choreography of STIM1-mediated Cell Signaling

Preclinical Evaluation of 131I/18F-Labeled Covalent Small-Molecule Inhibitors for STING Status Imaging

A Bioorthogonally Applicable, Fluorogenic, Large Stokes-Shift Probe for Intracellular Super-Resolution Imaging of Proteins

Structure−Activity Relationship Study of Benzothiophene Oxobutanoic Acid Analogues Leading to Novel Stimulator of Interferon Gene (STING) Agonists

Bioorthogonally activated probes for precise fluorescence imaging

18 F-Labeled Amidobenzimidazole Analogue for Visualizing STING Expression in Tumor

Design and syntheses of a bimolecular STING agonist based on the covalent STING antagonist

Bioorthogonally applicable multicolor fluorogenic naphthalimide-tetrazine probes with aggregation-induced emission characters

Discovery of Novel Thieno[2,3-d]imidazole Derivatives As Agonists of Human STING for Antitumor Immunotherapy Using Systemic Administration.

Photochemically controlled activation of STING by CAIX-targeting photocaged agonists to suppress tumor cell growth

Bioorthogonal Turn-On Probe Based on Aggregation-Induced Emission Characteristics for Cancer Cell Imaging and Ablation.

Bioorthogonally activatable cyanine dye with torsion-induced disaggregation for in vivo tumor imaging

Bioorthogonal Nanosystem for Near-Infrared Fluorescence Imaging and Prodrug Activation in Mouse Model

Affinity-Based Covalent Sialyltransferase Probes Enabled by Ligand-Directed Chemistry

A Fluorogenic Probe for Imaging Protein S-nitrosylation in Live Cells.

Discovery and Mechanistic Study of a Novel Human-Stimulator-of-Interferon-Genes Agonist

Noninvasive Imaging of Sialyltransferase Activity in Living Cells by Chemoselective Recognition

Computational study on new natural compound agonists of stimulator of interferon genes (STING)

Discovery of triazoloquinoxaline as novel STING agonists via structure-based virtual screening